186 related articles for article (PubMed ID: 12052817)
1. Fusidic acid cream for impetigo. Fusidic acid should be used with restraint.
Brown EM; Wise R
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12052817
[No Abstract] [Full Text] [Related]
2. Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use.
Weston VC; Boswell TC; Finch RG; Perkins W
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053928
[No Abstract] [Full Text] [Related]
3. Fusidic acid cream for impetigo. Findings cannot be extrapolated.
Owen SE; Cheesbrough JS
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053931
[No Abstract] [Full Text] [Related]
4. Fusidic acid cream for impetigo. Problem may be clinically important.
Stoddart B; Collyns T; Denton M
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053929
[No Abstract] [Full Text] [Related]
5. Fusidic acid cream for impetigo. Resistance trends must be monitored.
Zadik P; Young N
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053930
[No Abstract] [Full Text] [Related]
6. Fusidic acid cream for impetigo. Judicious use is advisable.
Sule O; Brown N; Brown DF; Burrows N
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053927
[No Abstract] [Full Text] [Related]
7. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial.
Koning S; van Suijlekom-Smit LW; Nouwen JL; Verduin CM; Bernsen RM; Oranje AP; Thomas S; van der Wouden JC
BMJ; 2002 Jan; 324(7331):203-6. PubMed ID: 11809642
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of antibacterials of Staphylococcus aureus isolated from impetigo patients.
Nishijima S; Nakagawa M
J Int Med Res; 1997; 25(4):210-3. PubMed ID: 9283995
[TBL] [Abstract][Full Text] [Related]
9. [Impetigo bullosa].
Tveten Y
Tidsskr Nor Laegeforen; 2003 Nov; 123(21):3089; author reply 3089. PubMed ID: 14618190
[No Abstract] [Full Text] [Related]
10. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
Alsterholm M; Flytström I; Bergbrant IM; Faergemann J
Acta Derm Venereol; 2010; 90(1):52-7. PubMed ID: 20107726
[TBL] [Abstract][Full Text] [Related]
11. Current options for the treatment of impetigo in children.
Sladden MJ; Johnston GA
Expert Opin Pharmacother; 2005 Oct; 6(13):2245-56. PubMed ID: 16218885
[TBL] [Abstract][Full Text] [Related]
12. Fusidic acid resistant Staphylococcus aureus and skin disease.
Lomholt HB
Acta Derm Venereol; 2010; 90(1):4. PubMed ID: 20107716
[No Abstract] [Full Text] [Related]
13. Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
Schachner LA; Andriessen A; Benjamin LT; Claro C; Eichenfield LF; Esposito SM; Keller L; Kircik L; Kwong PC; McCuaig C
J Drugs Dermatol; 2021 Feb; 20(2):134-142. PubMed ID: 33538559
[TBL] [Abstract][Full Text] [Related]
14. The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.
Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
Scand J Infect Dis; 2014 Dec; 46(12):832-7. PubMed ID: 25229166
[TBL] [Abstract][Full Text] [Related]
15. [An epidemic of bullous impetigo in the municipality of Austevoll in the year 2002].
Rørtveit S; Rørtveit G
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2557-60. PubMed ID: 14714041
[TBL] [Abstract][Full Text] [Related]
16. Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid.
Osterlund A; Eden T; Olsson-Liljequist B; Haeggman S; Kahlmeter G;
Scand J Infect Dis; 2002; 34(10):729-34. PubMed ID: 12477322
[TBL] [Abstract][Full Text] [Related]
17. Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics.
Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
J Antimicrob Chemother; 2011 Jun; 66(6):1360-4. PubMed ID: 21393202
[TBL] [Abstract][Full Text] [Related]
18. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.
Rijnders MI; Wolffs PF; Hopstaken RM; den Heyer M; Bruggeman CA; Stobberingh EE
J Antimicrob Chemother; 2012 May; 67(5):1176-80. PubMed ID: 22290345
[TBL] [Abstract][Full Text] [Related]
19. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.
Vogel A; Lennon D; Best E; Leversha A
N Z Med J; 2016 Oct; 129(1443):77-83. PubMed ID: 27736855
[TBL] [Abstract][Full Text] [Related]
20. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.
Laurent F; Tristan A; Croze M; Bes M; Meugnier H; Lina G; Vandenesch F; Etienne J
J Antimicrob Chemother; 2009 Feb; 63(2):420-1; author reply 421. PubMed ID: 18978362
[No Abstract] [Full Text] [Related]
[Next] [New Search]
